Applicant, as named in the Orange Book

Radius

Next listed expiry: Tymlos on 10 Jan 2040. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Tymlos abaloparatide	abaloparatide	208743	10 Jan 2040	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.